| Wyeth - SWOT Analysis company profile is the | | | | products, nutrition products, vaccines, and consumer |
| essential source for top-level company data and | | | | and animal healthcare products. The company sells its |
| information. Wyeth - SWOT Analysis examines the | | | | products in 145 countries worldwide. It is |
| company's key business structure and operations, | | | | headquartered in Madison, New Jersey and employed |
| history and products, and provides summary analysis | | | | 47,426 people as of December 2008. The company |
| of its key revenue lines and strategy. | | | | recorded revenues of $22,833.9 million during the |
| Wyeth, which is set to be part of the world's largest | | | | financial year (FY) ended December 2008, an increase |
| pharmaceutical company following the $68-billion | | | | of 1.9% over FY2007. The increase was mainly due |
| merger with Pfizer, is a diversified prescription | | | | to higher sales of Enbrel, Prevnar, and Zosyn. The |
| pharmaceuticals and healthcare products provider. | | | | operating profit of the company was $6,374.6 million |
| The company is engaged in the discovery, | | | | during FY2008, an increase of 4.9% over FY2007. |
| development, manufacture, distribution and sale of | | | | The net profit was $4,417.8 million in FY2008, a |
| human ethical pharmaceuticals, biotechnology | | | | decrease of 4.3% over FY2007. |